In vivo quantitative measurement of arthritis activity based on hydrophobically modified glycol chitosan in inflammatory arthritis: More active than passive accumulation

Molecular Imaging

Volumn 11, Issue 5, 2012, Pages 389-400

  Park, Kyeong Soon ^a,b   Kang, Jin Hee ^a,b   Sa, Keum Hee ^a,b   Koo, Hee Beom ^a,b   Cho, Hyun Jung ^a,b   Nam, Eon Jeong ^a,b   Youn, In Chan ^a,b   Kim, Kwang Meyung ^a,b   Kim, In San ^a,b   Kwon, Ick Chan ^a,b   Choi, Kui Won ^a,b   Kang, Young Mo ^a,b  

^a Korea Institute of Science and Technology   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED MACROPHAGES; ACTIVITY-BASED; AFTER-TREATMENT; COLLAGEN-INDUCED ARTHRITIS; DOSE-DEPENDENT MANNER; ENHANCED PERMEABILITY; FLUORESCENCE INTENSITIES; HYDROPHOBICALLY MODIFIED GLYCOL CHITOSANS; IN-VIVO; INFLAMMATORY ARTHRITIS; NEAR-INFRARED FLUORESCENCE; OBJECTIVE MEASUREMENT; OPTICAL IMAGING; OPTICAL IMAGING SYSTEM; PHOTON COUNT; PHYSIOLOGIC CONDITIONS; QUANTITATIVE MEASUREMENT; RHEUMATOID ARTHRITIS; SPHERICAL NANOPARTICLES;

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; CHITOSAN; FLUORESCENCE; GLYCOLS; MACROPHAGES; NANOPARTICLES; OPTICAL IMAGE STORAGE; TISSUE;

DISEASES;

CARBOCYANINE; CHITOSAN; CY5.5 CYANINE DYE; GLYCOL CHITOSAN; GLYCOL-CHITOSAN; METHOTREXATE; NANOPARTICLE;

ANALYSIS OF VARIANCE; ANIMAL; ARTHRITIS; ARTICLE; C57BL MOUSE; CASE CONTROL STUDY; CHEMICAL PHENOMENA; CHEMISTRY; CYTOLOGY; DBA MOUSE; DRUG MONITORING; FLUORESCENCE IMAGING; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; METABOLISM; METHODOLOGY; MOUSE; NEAR INFRARED SPECTROSCOPY; PATHOLOGY; PHAGOCYTOSIS; RANDOMIZATION; SYNOVIAL FLUID;

ANALYSIS OF VARIANCE; ANIMALS; ARTHRITIS, EXPERIMENTAL; CARBOCYANINES; CASE-CONTROL STUDIES; CHITOSAN; DRUG MONITORING; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; METHOTREXATE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NANOPARTICLES; OPTICAL IMAGING; PHAGOCYTOSIS; RANDOM ALLOCATION; SPECTROSCOPY, NEAR-INFRARED; SYNOVIAL FLUID;

EID: 84873923550     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00056     Document Type: Article

References (43)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61, doi:10.1038/nature01661.
2. .Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 2007;9 Suppl 2:S3, doi:10.1186/ar2187.
3. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429-42, doi:10.1038/nri2094.
4. Welsing PM, Landewe RB, van Riel PL, et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004;50:2082-93, doi:10.1002/art.20350.
5. Pincus T, Sokka T. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care. Best Pract Res Clin Rheumatol 2003;17:753-81, doi:10.1016/S1521-6942(03)00077-9.
6. Sullivan DC. Molecular imaging in oncology. Ann Oncol 2006;17 Suppl 10:x287-92, doi:10.1093/annonc/mdl275.
7. Weissleder R. Molecular imaging in cancer. Science 2006;312: 1168-71, doi:10.1126/science.1125949.
8. Wunder A, Straub RH, Gay S, et al. Molecular imaging: novel tools in visualizing rheumatoid arthritis. Rheumatology (Oxford) 2005; 44:1341-9, doi:10.1093/rheumatology/keh709.
9. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219:316-33.
10. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001;19:316-7, doi:10.1038/86684.
11. Chen WT, Mahmood U, Weissleder R, et al. Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther 2005;7:R310-7, doi:10.1186/ar1483.
12. Hansch A, Frey O, Sauner D, et al. In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum 2004;50: 961-7, doi:10.1002/art.20112.
13. Wunder A, Schellenberger E, Mahmood U, et al. Methotrexateinduced accumulation of fluorescent annexin V in collageninduced arthritis. Mol Imaging 2005;4:1-6.
14. Wunder A, Tung CH, Muller-Ladner U, et al. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004;50:2459-65, doi:10.1002/art.20379.
15. Biswal S, Resnick DL, Hoffman JM, et al. Molecular imaging: integration of molecular imaging into the musculoskeletal imaging practice. Radiology 2007;244:651-71, doi:10.1148/radiol.2443060295.
16. Park K, Kim JH, Nam YS, et al. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J Control Release 2007;122:305-14, doi:10.1016/j.jconrel.2007.04.009.
17. Cho YW, Park SA, Han TH, et al. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications. Biomaterials 2007;28: 1236-47, doi:10.1016/j.biomaterials.2006.10. 002.
18. Min KH, Park K, Kim YS, et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 2008;127:208-18, doi:10.1016/j.jconrel.2008.01.013.
19. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24, doi:10.1002/art.1780310302.
20. Nam EJ, Sa KH, You DW, et al. Up-regulated transforming growth factor beta-inducible gene h3 in rheumatoid arthritis mediates adhesion and migration of synoviocytes through alpha v beta3 integrin: regulation by cytokines. Arthritis Rheum 2006;54:2734- 44, doi:10.1002/art.22076.
21. Brownlie RJ, Myers LK, Wooley PH, et al. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin- 4-producing regulatory T cells: a novel function for an ancient protein. Arthritis Rheum 2006;54:854-63, doi:10.1002/art.21654.
22. Li J, Guo Y, Holmdahl R, et al. Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. Arthritis Rheum 2005;52:2541-8, doi:10.1002/art.21229.
23. Nandakumar KS, Svensson L, Holmdahl R. Collagen type IIspecific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003;163:1827-37, doi:10.1016/S0002-9440(10)63542-0.
24. Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta 2001 1514. 51-64.
25. Park K, Hong HY, Moon HJ, et al. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. J Control Release 2008;128:217-23, doi:10.1016/j.jconrel.2008.03.019.
26. Kim JH, Kim YS, Park K, et al. Antitumor efficacy of cisplatinloaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 2008;127:41-9, doi:10.1016/j.jconrel.2007.12.014.
27. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9: 653-60, doi:10.1038/nm0603-653.
28. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31, doi:10.1038/nm0195-27.
29. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res 2002;4 Suppl 3:S81-90, doi:10.1186/ar575.
30. Koch AE. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998;41:951-62, doi:10.1002/1529- 0131(199806)41:6,951::AID- ART2.3.0.CO;2-D.
31. Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80, doi:10.1016/S0002-9440(10)65006-7.
32. Baluk P, Hirata A, Thurston G, et al. Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am J Physiol 1997;272:L155-70.
33. Zhang Q, Lu Y, Proulx ST, et al. Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Arthritis Res Ther 2007; 9:R118, doi:10.1186/ar2326.
34. Kinne RW, Brauer R, Stuhlmuller B, et al. Macrophages in rheumatoid arthritis. Arthritis Res 2000;2:189-202, doi:10.1186/ ar86.
35. Tak PP, Smeets TJ, Daha MR, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997;40:217-25, doi:10.1002/ art.1780400206.
36. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996;39:115-24, doi:10.1002/art.1780390116.
37. Kinne RW, Stuhlmuller B, Burmester GR. Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther 2007;9:224, doi:10.1186/ar2333.
38. Dustin ML. In vivo imaging approaches in animal models of rheumatoid arthritis. Arthritis Res Ther 2003;5:165-71, doi:10.1186/ar768.
39. Kim K, Kwon S, Park JH, et al. Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. Biomacromolecules 2005;6:1154-8, doi:10.1021/bm 049305m.
40. Ntziachristos V, Tung CH, Bremer C, et al. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002;8: 757-60, doi:10.1038/nm729.
41. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-8, doi:10.1038/nm0103-123.
42. Kim JH, Kim YS, Kim S, et al. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release 2006;111:228-34, doi:10.1016/j.jconrel.2005.12.013.
43. Kim JH, Kim YS, Park K, et al. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials 2008;29:1920-30, doi:10.1016/j.biomaterials.2007.12.038.